Daewoong Pharmaceutical Co., Ltd (KRX:069620)

Daewoong Pharmaceutical Revenue

Daewoong Pharmaceutical had revenue of 448.46B KRW in the quarter ending June 30, 2026, with 10.61% growth. This brings the company's total for the last twelve months to 1.64T, up 9.87% year-over-year. In the year 2025, Daewoong Pharmaceutical had annual revenue of 1.57T with 10.42% growth. That makes Daewoong Pharmaceutical the 6,732nd largest company in the world by revenue and 299th in South Korea.

• Revenue (ttm): 1.64T
• Revenue Growth: +9.87%
• P/S Ratio: 0.70
• Revenue / Employee: 863.82M
• Employees: 1,893
• Market Cap: 1.16T

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical Manufacturing and Sales 1.60T 97.4%
• Service Provision 40.46B 2.5%
• Other 3.03B 0.2%

By Geography

Chart

• South Korea 1.37T 83.2%
• Export 275.83B 16.8%

Fiscal year ended Dec 31, 2025 See the full Daewoong Pharmaceutical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.57T	148.21B	10.42%
Dec 31, 2024	1.42T	47.35B	3.44%
Dec 31, 2023	1.38T	95.24B	7.44%
Dec 31, 2022	1.28T	127.12B	11.03%
Dec 31, 2021	1.15T	97.55B	9.24%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 25, 2026

Data Sources Report a data error